Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana

Sleep Medicine Reviews

Volumn 12, Issue 5, 2008, Pages 381-389

  Schierenbeck, Thomas ^a   Riemann, Dieter ^a   Berger, Mathias ^a   Hornyak, Magdolna ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cannabis; Cocaine; Ecstasy; Marijuana; Recreational drugs; Sleep; Tetrahydrocannabinol; Withdrawal

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE;

COGNITION; DRUG USE; POLYSOMNOGRAPHY; REVIEW; SLEEP DISORDER; SMOKING CESSATION;

ANIMALS; BRAIN; COCAINE; DISEASE MODELS, ANIMAL; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POLYSOMNOGRAPHY; SLEEP; SLEEP STAGES; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

EID: 51249114080     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2007.12.004     Document Type: Review

References (92)

1. National Institute on Drug Abuse. Monitoring the future. National results on adolescent drug use. Overview of key findings 2006 [Online]; 2006 [cited September 10, 2007] [76 screens]. Available from: .
2. National Survey on Drug Use and Health. Results from the 2006 National Survey on Drug Use and Health: national findings [Online]; 2006 [cited September 10, 2007] [282 screens]. Available from: .
3. Vetulani J. Drug addiction. Part II. Neurobiology of addiction. Pol J Pharmacol 53 (2001) 303-317
4. Smith D.E., Schwartz R.H., and Martin D.M. Heavy cocaine use by adolescents. Pediatrics 83 4 (1989) 539-542
5. Williamson S., Gossop M., Powis B., et al. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend 44 2/3 (1997) 87-94
6. Post R.M., Gillin J.C., Wyatt R.J., et al. The effect of orally administered cocaine on sleep of depressed patients. Psychopharmacologia 37 1 (1974) 59-66
7. Watson R., Bakos L., Compton P., et al. Cocaine use and withdrawal: the effect on sleep and mood. Am J Drug Alcohol Abuse 18 1 (1992) 21-28
8. Johanson C.E., Roehrs T., Schuh K., et al. The effects of cocaine on mood and sleep in cocaine-dependent males. Exp Clin Psychopharmacol 7 4 (1999) 338-346
9. Feinberg I., Hibi S., Cavness C., et al. Sleep amphetamine effects in MBDS and normal subjects. Arch Gen Psychiatry 31 5 (1974) 723-731
10. Brower K.J., Maddahian E., Blow F.C., et al. A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. Am J Drug Alcohol Abuse 14 3 (1988) 347-356
11. Cottler L.B., Shillington A.M., Compton W.M., et al. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. Drug Alcohol Depend 33 (1993) 97-104
12. Kowatch R.A., Schnoll S.S., Knisely J.S., et al. Electroencephalographic sleep and mood during cocaine withdrawal. J Addict Dis 11 4 (1992) 21-45
13. Gillin J.C., Pulvirenti L., Withers N., et al. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. Biol Psychiatry 35 (1994) 843-849
14. Thompson P.M., Gillin J.C., Golshan S., et al. Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol Psychiatry 38 12 (1995) 831-836
15. Lukas S.E., Dorsey C.M., Mello N.K., et al. Reversal of sleep disturbances in cocaine- and heroin-dependent men during chronic buprenorphine treatment. Exp Clin Psychopharmacol 4 4 (1996) 413-420
16. Pace-Schott E.F., Stickgold R., Muzur A., et al. Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacology 179 4 (2005) 873-883
17. Morgan P.T., Pace-Schott E.F., Sahul Z.H., et al. Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: evidence for occult insomnia. Drug Alcohol Depend 82 3 (2006) 238-249
18. Jacobs G.D., Pace-Schott E.F., Stickgold R., et al. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 164 17 (2004) 1888-1896
19. Dudish-Poulsen S., and Hatsukami D.K. Acute abstinence effects following smoked cocaine administration in humans. Exp Clin Psychopharmacol 8 4 (2000) 472-482
20. Pace-Schott E.F., Stickgold R., Muzur A., et al. Cognitive performance by humans during a smoked cocaine binge-abstinence cycle. Am J Drug Alcohol Abuse 31 4 (2005) 571-591
21. Graw P., Kräuchi K., Knoblauch V., et al. Circadian and wake-dependent modulation of fastest and slowest reaction times during the psychomotor vigilance task. Physiol Behav 80 5 (2004) 695-701
22. Gawin F.H., and Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 43 (1986) 107-113
23. Weddington W.W., Brown B.S., Haertzen C.A., et al. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry 47 9 (1990) 861-868
24. Krystal A.D., Edinger J.D., Wohlgemuth W.K., et al. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 25 6 (2002) 630-640
25. Green A.R., Mechan A.O., Elliott J.M., et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55 3 (2003) 463-508
26. Verheyden S.L., Henry J.A., and Curran H.V. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Hum Psychopharmacol 18 7 (2003) 507-517
27. Huxster J.K., Pirona A., and Morgan M.J. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol 20 2 (2006) 281-290
28. Gouzoulis E., Steiger A., Ensslin M., et al. Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers. Biol Psychiatry 32 12 (1992) 1108-1117
29. Gouzoulis-Mayfrank E., and Daumann J. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?. Addiction 101 3 (2006) 348-361
30. Cohen R.S. Subjective reports on the effects of the MDMA ('ecstasy') experience in humans. Prog Neuropsychopharmacol Biol Psychiatry 19 7 (1995) 1137-1145
31. Parrott A.C., Sisk E., and Turner J.J. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug Alcohol Depend 60 1 (2000) 105-110
32. Dughiero G., Schifano F., and Forza G. Personality dimensions and psychopathological profile of ecstasy users. Hum Psychopharmacol Clin 16 8 (2001) 635-639
33. McCann U.D., Peterson S.C., and Ricaurte G.A. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology 32 (2007) 1695-1706
34. Allen R.P., McCann U.D., and Ricaurte G.A. Persistent effects of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. Sleep 16 6 (1993) 560-564
35. Ricaurte G.A., and McCann U.D. Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its potential to damage brain serotonin neurons. Neurotoxicity Res 3 1 (2001) 85-99
36. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42 4 (2003) 327-360
37. Iversen L. Cannabis and the brain. Brain 126 (2003) 1252-1270
38. Cousens K., and DiMascio A. (-) Delta 9 THC as an hypnotic. An experimental study of three dose levels. Psychopharmacologia 33 4 (1973) 355-364
39. Chait L.D. Subjective and behavioral effects of marijuana the morning after smoking. Psychopharmacology 100 3 (1990) 328-333
40. Haney M., Hart C.L., Vosburg S.K., et al. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29 1 (2004) 158-170
41. Tassinari C.A., Ambrosetto G., Peraita-Adrado M.R., et al. The neuropsychiatric syndrome of Δ-9-tetrahydrocannabinol and cannabis intoxication in naive subjects: a clinical and polygraphic study during wakefulness and sleep. In: Braude M.C., and Szara S. (Eds). Pharmacology of marijuana (1976), Raven Press, New York 357-375
42. Gillin J.C., Kotin J., Post R., et al. Sleep during one week of administration of Δ-9 tetrahydrocanabinol to psychiatric patients. J Sleep Res 1 (1972) 44
43. Bobon D.P., Schulz H., Mattke D., et al. Influence of synthetic-8-tetrahydrocannabinol on all-night sleep EEG in man. In: Jovanovic U.J. (Ed). The nature of sleep (1973), Gustav Fischer Verlag, Stuttgart
44. Hosko M.J., Kochar M.S., and Wang R.I. Effects of orally administered delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther 14 3 (1973) 344-352
45. Barratt E.S., Beaver W., and White R. The effects of marijuana on human sleep patterns. Biol Psychiatry 8 1 (1974) 47-54
46. Feinberg I., Jones R., Walker J.M., et al. Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther 17 4 (1975) 458-466
47. Nicholson A.N., Turner C., Stone B.M., et al. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24 3 (2004) 305-313
48. Kales A., Hanley J., Rickles W., et al. Effects of marijuana administration and withdrawal in chronic users and naïve subjects. Psychophysiology 9 (1972) 92
49. Freemon F.R. Effects of marihuana on sleeping states. JAMA 220 10 (1972) 1364-1365
50. Feinberg I., Jones R., Walker J., et al. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther 19 6 (1976) 782-794
51. Freemon F.R. The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers. Drug Alcohol Depend 10 4 (1982) 345-353
52. Pranikoff K., Karacan I., Larson E.A., et al. Effects of marijuana smoking on the sleep EEG. Preliminary studies. J Fla Med Assoc 60 3 (1973) 28-31
53. Karacan I., Fernandez-Salas A., Coggins W.J., et al. Sleep electroencephalographic-electrooculographic characteristics of chronic marijuana users: part I. Ann N Y Acad Sci 282 (1976) 348-374
54. Halikas J.A., Weller R.A., Morse C.L., et al. A longitudinal study of marijuana effects. Int J Addict 20 5 (1985) 701-711
55. Budney A.J., Hughes J.R., Moore B.A., et al. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 161 11 (2004) 1967-1977
56. Vandrey R., Budney A.J., Kamon J.L., et al. Cannabis withdrawal in adolescent treatment seekers. Drug Alcohol Depend 78 2 (2005) 205-210
57. Copersino M.L., Boyd S.J., Tashkin D.P., et al. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict 15 1 (2006) 8-14
58. Vandrey R.G., Budney A.J., Moore B.A., et al. A cross-study comparison of cannabis and tobacco withdrawal. Am J Addict 14 1 (2005) 54-63
59. Vandrey RG, Budney AJ, Hughes JR, et al. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend, in press.
60. Budney A.J., Moore B.A., Vandrey R.G., et al. The time course and significance of cannabis withdrawal. J Abnorm Psychol 112 3 (2003) 393-402
61. Jones R.T., Benowitz N., and Bachman J. Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci 282 (1976) 221-239
62. Haney M., Ward A.S., Comer S.D., et al. Abstinence symptoms following oral THC administration to humans. Psychopharmacology 141 4 (1999) 385-394
63. Budney A.J., Hughes J.R., Moore B.A., et al. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry 58 10 (2001) 917-924
64. Budney A.J., Vandrey R.G., Hughes J.R., et al. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend 86 1 (2007) 22-29
65. Pivik R.T., Zarcone V., Dement W.C., et al. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther 13 3 (1972) 426-435
66. Flynn P.M., Kristiansen P.L., Porto J.V., et al. Costs and benefits of treatment for cocaine addiction in DATOS. Drug Alcohol Depend 57 (1999) 167-174
67. French M.T., Roebuck M.C., Dennis M.L., et al. The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment. Addiction 97 (2002) S84-S97
68. Poling J., Kosten T.R., and Sofuoglu M. Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse 33 2 (2007) 191-206
69. Crowley T.J., Macdonald M.J., Whitmore E.A., et al. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 50 1 (1998) 27-37
70. Stephens R.S., Babor T.F., Kadden R., et al. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction 97 (2002) 109-124
71. Gillin J.C., Smith T.L., Irwin M., et al. Increased pressure for rapid eye movement sleep at time of hopital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry 51 (1994) 189-197
72. Brower K.J., Aldrich M.S., and Hall J.M. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 22 (1998) 1864-1871
73. Gann H., Feige B., Hohagen F., et al. Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence. Biol Psychiatry 50 5 (2001) 383-390
74. Monnelly E.P., Ciraulo D.A., Knapp C., et al. Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 24 5 (2004) 532-535
75. Sofuoglu M., and Kosten T.R. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs 11 1 (2006) 91-98
76. Roberts D.C. Preclinical evidence for GABA-B agonists as a pharmacotherapy for cocaine addiction. Physiol Behav 86 1/2 (2005) 18-20
77. Haney M., Hart C.L., and Foltin R.W. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 31 8 (2006) 1814-1821
78. Dackis C.A., Kampman K.M., Lynch K.G., et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 1 (2005) 205-211
79. Hart CL, Haney M, Vosburg SK, et al. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology, in press.
80. Wesensten N.J. Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 12 20 (2006) 2457-2471
81. Kruszewski S.P. Euphorigenic and abusive properties of modafinil. Am J Psychiatry 163 3 (2006) 549
82. O'Brien C.P., Dackis C.A., and Kampman K. Does modafinil produce euphoria?. Am J Psychiatry 163 6 (2006) 1109
83. Voderholzer U., Hornyak M., Thiel B., et al. Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18 2 (1998) 112-124
84. Bhatti T., Gillin J.C., Seifritz E., et al. Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood. Biol Psychiatry 43 1 (1998) 52-59
85. Huwig-Poppe C., Voderholzer U., Backhaus J., et al. The tryptophan depletion test. Impact on sleep in healthy subjects and patients with obsessive-compulsive disorder. Adv Exp Med Biol 467 (1999) 35-42
86. Voderholzer U., Riemann D., Huwig-Poppe C., et al. Sleep in obsessive compulsive disorder. Polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency. Eur Arch Psychiatry Clin Neurosci 257 3 (2007) 173-182
87. Moore P., Gillin J.C., Bhatti T., et al. Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 55 (1998) 534-539
88. Riemann D., Feige B., Hornyak M., et al. The tryptophan depletion test: impact on sleep in primary insomnia-a pilot study. Psychiatry Res 109 2 (2002) 129-135
89. Walther S., Mahlberg R., Eichmann U., et al. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology 185 4 (2006) 524-528
90. Lee P.E., Gill S.S., Freedman M., et al. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 329 7457 (2004) 75
91. Daiello L.A. Atypical antipsychotics for the treatment of dementia-related behaviors: an update. Med Health R I 90 6 (2007) 191-194
92. Russo E.B., Guy G.W., and Robson P.J. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4 8 (2007) 1729-1743